Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,799 | 301 | 84.9% |
| Consulting Fee | $450.00 | 3 | 10.1% |
| Education | $201.89 | 4 | 4.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $24.41 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $1,459 | 176 | $0 (2020) |
| Biogen, Inc. | $700.67 | 18 | $0 (2021) |
| UCB, Inc. | $395.90 | 26 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $370.93 | 13 | $0 (2019) |
| Eisai Inc. | $313.44 | 15 | $0 (2023) |
| GENZYME CORPORATION | $275.51 | 16 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $241.99 | 14 | $0 (2019) |
| Allergan Inc. | $188.62 | 6 | $0 (2017) |
| ACADIA Pharmaceuticals Inc | $104.00 | 5 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $65.61 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $75.27 | 3 | Smith+Nephew, Inc. ($44.97) |
| 2023 | $51.92 | 2 | ACADIA Pharmaceuticals Inc ($29.77) |
| 2022 | $68.68 | 3 | UCB, Inc. ($25.63) |
| 2021 | $437.46 | 8 | Biogen, Inc. ($300.00) |
| 2020 | $153.24 | 8 | Sunovion Pharmaceuticals Inc. ($153.24) |
| 2019 | $694.05 | 54 | Sunovion Pharmaceuticals Inc. ($320.27) |
| 2018 | $1,358 | 97 | Sunovion Pharmaceuticals Inc. ($567.05) |
| 2017 | $1,637 | 134 | Sunovion Pharmaceuticals Inc. ($418.68) |
All Payment Transactions
309 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/18/2024 | Smith+Nephew, Inc. | Bone Anchors with Arthroscopic Delivery System (Device) | Food and Beverage | In-kind items and services | $44.97 | General |
| Category: Extremities & Limb Restoration | ||||||
| 09/04/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/09/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $29.77 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 04/26/2023 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $22.15 | General |
| Category: Neurology | ||||||
| 11/08/2022 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: Neurology | ||||||
| 08/18/2022 | EISAI INC. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $24.94 | General |
| Category: Neurology | ||||||
| 03/30/2022 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $18.11 | General |
| 12/16/2021 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $25.01 | General |
| 12/07/2021 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $20.61 | General |
| Category: Neurology | ||||||
| 09/21/2021 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $24.36 | General |
| Category: Neurology | ||||||
| 08/31/2021 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $24.03 | General |
| Category: Neurology | ||||||
| 07/29/2021 | Biogen, Inc. | TYSABRI (Biological) | Consulting Fee | Cash or cash equivalent | $150.00 | General |
| Category: NEUROLOGY | ||||||
| 07/28/2021 | Biogen, Inc. | TYSABRI (Biological) | Consulting Fee | Cash or cash equivalent | $150.00 | General |
| Category: NEUROLOGY | ||||||
| 07/13/2021 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $20.75 | General |
| Category: Neurology | ||||||
| 01/28/2021 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $22.70 | General |
| Category: Neurology | ||||||
| 08/11/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: CNS | ||||||
| 07/01/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $5.26 | General |
| Category: CNS | ||||||
| 06/04/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: CNS | ||||||
| 06/03/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: CNS | ||||||
| 06/03/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $10.67 | General |
| Category: CNS | ||||||
| 06/02/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: CNS | ||||||
| 05/28/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: CNS | ||||||
| 05/05/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $23.11 | General |
| Category: CNS | ||||||
| 11/19/2019 | Biogen, Inc. | TYSABRI (Biological), TECFIDERA | Food and Beverage | In-kind items and services | $11.02 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 101 | 559 | $101,967 | $28,499 |
| 2022 | 5 | 200 | 692 | $144,923 | $35,846 |
| 2021 | 8 | 324 | 1,596 | $297,594 | $73,494 |
| 2020 | 8 | 305 | 1,032 | $219,383 | $59,197 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 39 | 476 | $71,400 | $19,154 | 26.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 36 | 38 | $18,810 | $5,323 | 28.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 16 | $3,040 | $2,169 | 71.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 29 | $8,717 | $1,853 | 21.3% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 55 | 486 | $72,900 | $15,233 | 20.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 61 | 65 | $32,175 | $10,270 | 31.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 29 | 77 | $23,146 | $4,412 | 19.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 15 | 24 | $4,560 | $3,003 | 65.9% |
| 99356 | Extended inpatient or observation hospital service, first hour | Facility | 2022 | 40 | 40 | $12,142 | $2,928 | 24.1% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 68 | 1,196 | $179,400 | $37,650 | 21.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 59 | 59 | $29,205 | $9,687 | 33.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 43 | 59 | $11,210 | $7,703 | 68.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 41 | 116 | $34,870 | $6,836 | 19.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 26 | 50 | $18,750 | $4,235 | 22.6% |
| 99356 | Prolonged inpatient or observation hospital service, first hour | Facility | 2021 | 42 | 47 | $14,266 | $3,525 | 24.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 13 | 13 | $5,525 | $2,336 | 42.3% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2021 | 32 | 56 | $4,368 | $1,523 | 34.9% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 53 | 616 | $92,400 | $20,051 | 21.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 59 | 89 | $16,910 | $8,842 | 52.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 50 | 50 | $24,750 | $8,366 | 33.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 31 | 138 | $41,483 | $8,273 | 19.9% |
| 99354 | Prolonged office or other outpatient service first hour | Office | 2020 | 45 | 61 | $16,263 | $6,057 | 37.2% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 18 | 18 | $7,650 | $2,783 | 36.4% |
| 99356 | Prolonged inpatient or observation hospital service first hour | Facility | 2020 | 36 | 36 | $10,927 | $2,754 | 25.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 13 | 24 | $9,000 | $2,072 | 23.0% |
About Dr. Bruce Levy, M.D
Dr. Bruce Levy, M.D is a Neurology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114988680.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Levy, M.D has received a total of $4,475 in payments from pharmaceutical and medical device companies, with $75.27 received in 2024. These payments were reported across 309 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($3,799).
As a Medicare-enrolled provider, Levy has provided services to 930 Medicare beneficiaries, totaling 3,879 services with total Medicare billing of $197,036. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Houston, TX
- Active Since 03/31/2006
- Last Updated 11/03/2008
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1114988680
Products in Payments
- APTIOM (Drug) $1,459
- TYSABRI (Biological) $637.13
- Fycompa (Drug) $313.44
- AUBAGIO (Drug) $267.93
- Briviact (Drug) $236.33
- GILENYA (Drug) $184.65
- Vimpat (Drug) $159.57
- COPAXONE (Drug) $144.18
- NAMENDA XR (Drug) $143.45
- NUPLAZID (Drug) $104.00
- ACTHAR (Biological) $65.61
- TECFIDERA (Drug) $63.54
- Betaseron (Drug) $58.22
- NAMZARIC (Drug) $45.17
- Bone Anchors with Arthroscopic Delivery System (Device) $44.97
- Gamunex-C (Biological) $44.76
- AIMOVIG (Biological) $36.59
- NORTHERA (Drug) $35.62
- AJOVY (Drug) $24.86
- AMPYRA (Drug) $24.41
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Houston
William Ondo, M.d, M.D
Neurology — Payments: $1.5M
Dr. Annette Howard, Md, MD
Neurology — Payments: $1.2M
Paul Schulz, M.d, M.D
Neurology — Payments: $943,067
Amit Verma, Md, MD
Neurology — Payments: $817,815
Dr. Randolph Evans, Md, MD
Neurology — Payments: $715,948
Dr. John Volpi, Md, MD
Neurology — Payments: $569,676